BioAge raises $170M as obesity spotlight shifts to oral options, muscle preservers

BioAge Labs has reeled in the biotech industry’s largest private financing round so far in 2024 as the California startup goes full throttle on the hottest areas in obesity drug development: oral formulations and muscle preservation.

The biotech, which emerged as one of the anti-aging players in 2015, is moving…
Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks